Last reviewed · How we verify
NCT06714929
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
NA trial testing Hydration in Dental Caries in 7,200 participants. Currently enrolling.
31 May 2027
Quick facts
| Lead sponsor | Virginia Commonwealth University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 7,200 |
| Start date | 14 August 2024 |
| Primary completion | 31 May 2027 |
| Estimated completion | 31 May 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hydration — full drug profile →
Conditions studied
- Dental Caries — all drugs for Dental Caries →
- Obesity Prevention — all drugs for Obesity Prevention →
Sponsor
Virginia Commonwealth University
Who can join
4 and older, any sex, with Dental Caries or Obesity Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to determine the effectiveness and sustainability of a community-participatory hydration intervention over 3 years within a district that has newly installed hydration stations and is operating under a policy designed to enhance heathy hydration practices and promote equitable access to drinking water.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06714929
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hydration
Trials testing the same drug.
- NCT07291375 — Role of Amlodipine in Reduction of CIN · EARLY_PHASE1 · not yet recruiting
- NCT04150666 — The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP) · NA · withdrawn
Other recruiting trials for Dental Caries
Currently open trials in the same condition.
- NCT06787261 — Involvement of Archaea in Carious Disease · NA · recruiting
- NCT06753669 — Mothers' Action Project for Child Health · NA · recruiting
- NCT07431463 — Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary T · NA · active not recruiting
- NCT07134114 — Occlusal Impact of Hall Crowns in Primary Molars · NA · recruiting
- NCT07181967 — SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children · NA · recruiting
Other Virginia Commonwealth University trials
Trials by the same sponsor.
- NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
- NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
- NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
- NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
- NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06714929 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06714929.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing